MGT Capital Investments (MGT) Cash Flow Statement

Click line-items for a historical chart and %

Net loss before non-controlling interest	-18.58M
Loss from discontinued operations
Stock-based compensation expense	10.54M
Depreciation	30K
Accrued interest
Assignment of Medicsight stock to D4D
Gain on sale of loan receivable - related party
Profit on disposal of Medicexchange and other investments
Accounts receivable	0
Other receivable - related party
Prepaid expenses and other current assets	-130K
Accounts payable	210K
Accrued expenses	95K
Other payables
Net cash used in operating activities	-3.77M
Issuance of Moneygate loans receivable
Cash in Medicexchange subsidiaries disposed of
Receipt of Dunamis loan repayment
Purchase of property, plant and equipment	-321K
Receipts from sale of Moneygate
Receipts of deferred consideration for sale of assets
Receipts from sale of Medicsight’s stock
Net cash used in investing activities
Net cash used in Medicexchange operating activities	0
Net cash used in discontinued operations
Effects of exchange rates on cash and cash equivalents
Net change in cash and cash equivalents	1.75M
Cash and cash equivalents, beginning of period	359K
Cash and cash equivalents, end of period	2.11M

Entities mentioned with MGT

View All Entities